Related references
Note: Only part of the references are listed.Clinical and Pathological Aspects of Silent Pituitary Adenomas
Juliana Drummond et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Can the molecular typing of the specific adenohypophyseal hormone genes be useful in the management of pituitary neuroendocrine tumours?
Raquel Miralles Moragrega et al.
ENDOCRINOLOGIA DIABETES Y NUTRICION (2019)
Is it time to consider the expression of specific-pituitary hormone genes when typifying pituitary tumours?
Araceli Garcia-Martinez et al.
PLOS ONE (2018)
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
S. L. Asa et al.
ENDOCRINE-RELATED CANCER (2017)
Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas
Laura Sanchez-Tejada et al.
PLOS ONE (2017)
The gonadotroph origin of null cell adenomas
George Kontogeorgos et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2016)
The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas
Hiroshi Nishioka et al.
ENDOCRINE PATHOLOGY (2015)
The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study
Tomas Thor Agustsson et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Isolated double pituitary adenomas: A silent corticotroph adenoma and a microprolactinoma
Shira Eytan et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
A rare case of ACTH-LH plurihormonal pituitary adenoma: letter to the editor
Alessandro Villa et al.
ACTA NEUROCHIRURGICA (2014)
Pasireotide therapy in a rare and unusual case of plurihormonal pituitary macroadenoma
Rajesh Rajendran et al.
ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS (2013)
Silent Corticogonadotroph Adenomas: Clinical and Cellular Characteristics and Long-Term Outcomes
Odelia Cooper et al.
Hormones & Cancer (2010)
Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience
D. Erickson et al.
CLINICAL ENDOCRINOLOGY (2009)
Expression of adrenocorticotropic hormone, prolactin and transcriptional factors in clinically nonfunctioning pituitary adenoma
Kazunori Kageyama et al.
ENDOCRINE JOURNAL (2007)
The 2004 World Health Organization classification of pituitary tumors: What is new?
M Al-Shraim et al.
ACTA NEUROPATHOLOGICA (2006)
The prevalence of pituitary adenomas - A systematic review
S Ezzat et al.
CANCER (2004)
Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs
S Vallette-Kasic et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Expression of GATA-2 in human pituitary adenomas
K Umeoka et al.
MODERN PATHOLOGY (2002)
A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins
B Lamolet et al.
CELL (2001)
Pituitary hormone mRNA in null cell adenomas and oncocytomas by in situ hybridization comparison with immunohistochemical and clinical data
M Schmid et al.
PATHOLOGY RESEARCH AND PRACTICE (2001)
Share Paper
